Over 5 lakh Tramadol, Alprazolam tablets worth Rs 20 crore seized,; 5 arrested

Written By :  Ruchika Sharma
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2025-08-04 07:51 GMT   |   Update On 2025-08-04 07:51 GMT
Advertisement

New Delhi: The Narcotics Control Bureau (NCB) has uncovered a syndicate involved in illegally diverting pharma drugs across Uttar Pradesh and Uttarakhand, seizing over five lakh tablets of Tramadol and Alprazolam valued at Rs 20 crore and arresting five people linked to the illegal operation.

The bust is the result of three targeted operations that began in May across Dehradun and Jaspur in Uttarakhand, and Muzaffarnagar, Bareilly, and Saharanpur in western Uttar Pradesh, the central anti-drug agency said in a statement on Sunday.

The agency found that a milk vendor from UP had "leased out" his wholesale drug sale licence for Rs 5,000 per month to the syndicate that illegally diverted pharmaceutical and prescription drugs.
"The syndicate included fake wholesalers and mixsused drug sale licences. Investigation is on to identify and apprehend the mastermind behind the network," the NCB said.
Local enforcement agencies like police and state anti-narcotics agencies have been sensitised for follow-up action, it said.
Advertisement
As per PTI, the NCB said it has seized about 5 lakh Tramadol and Alprazolam tablets, worth Rs 20 crore, as part of these operations apart from the arrest of five persons.
Tramadol is a synthetic opioid-like drug used as a painkiller. It was declared a "psychotropic substance" by India in 2018 and its sale in the country is regulated and monitored by the NCB.
Alprazolam is a prescription drug which is often misused as recreational drug and for mixing with Toddy, a alcoholic beverage.
Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News